ClariTrial — AI Clinical Trial Intelligence

Explore/Breast Cancer

Status

Phase

18,443 results for “Breast Cancer”

Page 1 of 1230

NCT05228743

UNKNOWN

Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer

N/AGastric Cancer

Comparing Hyperthermic Intraperitoneal ChemotherapyPaclitaxelS1

Tianjin Medical University Cancer Institute and Hospital180 participants1 site · ChinaCompletes Aug 2023

CT.gov Full analysis →

NCT05665660

Completed

Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening

N/ABreast Cancer

CARECARE + COACH

Johns Hopkins Bloomberg School of Public Health323 participants1 site · United StatesCompletes Sep 2025

CT.gov Full analysis →

NCT05411380

UNKNOWN

Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

Phase 2Breast Cancer

TucidinostatCapecitabineEndocrine Therapy

wang shusen73 participants1 site · ChinaCompletes Apr 2024

CT.gov Full analysis →

NCT06441188

Completed

Sonography of the Nipple Areolar Complex

N/AHealthy

Thin layer conventional ultrasound coupling gelThick layer of conventional ultrasound coupling gelThin conventional ultrasound coupling gel pad+1 more

Mayo Clinic20 participants1 site · United StatesCompletes Oct 2024

CT.gov Full analysis →

NCT06727227

Recruiting

Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer

N/ABreast Cancer

trastuzumab deruxtecan

AstraZeneca135 participants14 sites · Bulgaria, SloveniaCompletes Oct 2027

CT.gov Full analysis →

NCT00375427

Completed

Results posted

Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions

Phase 3Breast Cancer With Bone Metastasis

Zoledronic acid

Novartis Pharmaceuticals430 participants1 site · ItalyCompletes Feb 2010

CT.gov Full analysis →

NCT05111561

Suspended

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

Phase 1Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm

BET Bromodomain Inhibitor ZEN-3694BinimetinibBiopsy Procedure+3 more

National Cancer Institute (NCI)42 participants4 sites · United StatesCompletes Mar 2027

CT.gov Full analysis →

NCT04029961

Terminated

Results posted

Virtual Reality Education Program to Reduce Anxiety During Radiation Therapy

N/AAnxietyStressSatisfaction, Patient

Video EducationVR-based Education

Medical College of Wisconsin28 participants1 site · United StatesCompletes Apr 2020

CT.gov Full analysis →

NCT05826197

UNKNOWN

Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics

N/ABreast Neoplasms

Radiomics

First Affiliated Hospital Xi'an Jiaotong University100 participantsCompletes May 2024

CT.gov Full analysis →

NCT04937660

Completed

Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

N/AMetastatic Breast Cancer

Pfizer185 participants12 sites · Egypt, Jordan, LebanonCompletes Apr 2025

CT.gov Full analysis →

NCT02541188

Terminated

Genotype and Phenotype in Early Onset Breast Cancer in Young Women on the Two Shores of the Mediterranean Sea

N/ABreast Cancer

Genetic analysis

University Hospital, Montpellier460 participants1 site · FranceCompletes Oct 2016

CT.gov Full analysis →

NCT05797727

Completed

Real-Life Pilot Feasibility Study (LC_RLP)

N/ABreast CancerProstate Cancer

LifeChamps Platform HCPLifeChamps Platform

Aristotle University Of Thessaloniki121 participants1 site · GreeceCompletes Nov 2023

CT.gov Full analysis →

NCT02255461

Terminated

Results posted

Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Phase 1Childhood Choroid Plexus TumorChildhood EpendymoblastomaChildhood Grade III Meningioma

palbociclib isethionatepharmacological studylaboratory biomarker analysis

Pediatric Brain Tumor Consortium35 participants11 sites · United StatesCompletes Feb 2019

CT.gov Full analysis →

NCT04666961

Recruiting

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

Phase 2Ductal Carcinoma in SituExtensive DiseaseMastectomy

Tamoxifen 20 mgAnastrozole 1Mg Tab

Institut Cancerologie de l'Ouest262 participants8 sites · FranceCompletes Aug 2024

CT.gov Full analysis →

NCT04003142

Completed

Results posted

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2

Phase 3Hot Flashes

Fezolinetantplacebo

Astellas Pharma Global Development, Inc.501 participants93 sites · United States, Canada, CzechiaCompletes Jul 2020

CT.gov Full analysis →

1–15 of 18,443

Explore/Breast Cancer

Status

Phase

18,443 results for “Breast Cancer”

Page 1 of 1230

NCT05228743

UNKNOWN

Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer

N/AGastric Cancer

Comparing Hyperthermic Intraperitoneal ChemotherapyPaclitaxelS1

Tianjin Medical University Cancer Institute and Hospital180 participants1 site · ChinaCompletes Aug 2023

CT.gov Full analysis →

NCT05665660

Completed

Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening

N/ABreast Cancer

CARECARE + COACH

Johns Hopkins Bloomberg School of Public Health323 participants1 site · United StatesCompletes Sep 2025

CT.gov Full analysis →

NCT05411380

UNKNOWN

Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

Phase 2Breast Cancer

TucidinostatCapecitabineEndocrine Therapy

wang shusen73 participants1 site · ChinaCompletes Apr 2024

CT.gov Full analysis →

NCT06441188

Completed

Sonography of the Nipple Areolar Complex

N/AHealthy

Thin layer conventional ultrasound coupling gelThick layer of conventional ultrasound coupling gelThin conventional ultrasound coupling gel pad+1 more

Mayo Clinic20 participants1 site · United StatesCompletes Oct 2024

CT.gov Full analysis →

NCT06727227

Recruiting

Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer

N/ABreast Cancer

trastuzumab deruxtecan

AstraZeneca135 participants14 sites · Bulgaria, SloveniaCompletes Oct 2027

CT.gov Full analysis →

NCT00375427

Completed

Results posted

Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions

Phase 3Breast Cancer With Bone Metastasis

Zoledronic acid

Novartis Pharmaceuticals430 participants1 site · ItalyCompletes Feb 2010

CT.gov Full analysis →

NCT05111561

Suspended

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

Phase 1Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm

BET Bromodomain Inhibitor ZEN-3694BinimetinibBiopsy Procedure+3 more

National Cancer Institute (NCI)42 participants4 sites · United StatesCompletes Mar 2027

CT.gov Full analysis →

NCT04029961

Terminated

Results posted

Virtual Reality Education Program to Reduce Anxiety During Radiation Therapy

N/AAnxietyStressSatisfaction, Patient

Video EducationVR-based Education

Medical College of Wisconsin28 participants1 site · United StatesCompletes Apr 2020

CT.gov Full analysis →

NCT05826197

UNKNOWN

Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics

N/ABreast Neoplasms

Radiomics

First Affiliated Hospital Xi'an Jiaotong University100 participantsCompletes May 2024

CT.gov Full analysis →

NCT04937660

Completed

Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

N/AMetastatic Breast Cancer

Pfizer185 participants12 sites · Egypt, Jordan, LebanonCompletes Apr 2025

CT.gov Full analysis →

NCT02541188

Terminated

Genotype and Phenotype in Early Onset Breast Cancer in Young Women on the Two Shores of the Mediterranean Sea

N/ABreast Cancer

Genetic analysis

University Hospital, Montpellier460 participants1 site · FranceCompletes Oct 2016

CT.gov Full analysis →

NCT05797727

Completed

Real-Life Pilot Feasibility Study (LC_RLP)

N/ABreast CancerProstate Cancer

LifeChamps Platform HCPLifeChamps Platform

Aristotle University Of Thessaloniki121 participants1 site · GreeceCompletes Nov 2023

CT.gov Full analysis →

NCT02255461

Terminated

Results posted

Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Phase 1Childhood Choroid Plexus TumorChildhood EpendymoblastomaChildhood Grade III Meningioma

palbociclib isethionatepharmacological studylaboratory biomarker analysis

Pediatric Brain Tumor Consortium35 participants11 sites · United StatesCompletes Feb 2019

CT.gov Full analysis →

NCT04666961

Recruiting

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

Phase 2Ductal Carcinoma in SituExtensive DiseaseMastectomy

Tamoxifen 20 mgAnastrozole 1Mg Tab

Institut Cancerologie de l'Ouest262 participants8 sites · FranceCompletes Aug 2024

CT.gov Full analysis →

NCT04003142

Completed

Results posted

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2

Phase 3Hot Flashes

Fezolinetantplacebo

Astellas Pharma Global Development, Inc.501 participants93 sites · United States, Canada, CzechiaCompletes Jul 2020

CT.gov Full analysis →

1–15 of 18,443